Written and maintained by CASRAI Editorial Board
Last updated
A genetic testing lab’s collection station is not stocked like a general-purpose draw room. Two collection paths run through it — buccal (cheek) swab kits for saliva-adjacent DNA collection, and blood draw kits for whole-blood-derived DNA and RNA testing — and the two are not interchangeable substitutes for whatever happens to be on the shelf. The test being ordered dictates which path is used, and each path carries its own stabilization chemistry, labeling requirements, and shelf-life risk that a general phlebotomy stock list does not cover. On top of that, genetic results carry legal, insurance, and identity weight that most routine lab work doesn’t, so the collection station also has to support an unbroken chain of custody from the moment a sample is drawn to the moment it lands at the testing bench. This checklist covers what a genetic testing lab’s specimen-collection station needs to stock across both collection paths, plus the chain-of-custody basics that keep a sample defensible once it’s collected.
Where to source this: LAC (lac.us), CASRAI’s sister medical-supply business under the same operator, stocks several of the core categories on this list directly — Butterfly Infusion Sets, Alcohol Prep Pads, and Medical Filters for Clinical & Laboratory Use. This is a real, first-party sourcing option, not a paid placement or a third-party affiliate link, and not a requirement to buy from a specific vendor — use whatever distributor already carries the grades and lot-tracked stabilizer products your lab has standardized on.
Buccal Swab Collection Kits: What to Stock
A buccal swab kit is the lower-invasiveness path: no needle, no bleeding, and a collection a trained non-clinical staff member (or, for direct-to-consumer and some pharmacogenomic programs, the patient themselves under written instructions) can perform. The station needs foam-tipped or flocked swabs sized for cheek-mucosa collection, not the thinner swabs used for wound or nasal sampling — the wider, more absorbent head is what collects an adequate epithelial cell yield. Stock kits at the collection count the assay actually validates against; many genetic panels specify two to four swabs per collection to reach a reliable DNA yield, and a station that only keeps single swabs on hand will systematically under-collect.
Storage format matters as much as the swab itself. Some kits use a dry paper envelope or a desiccant-sealed pouch that air-dries the sample; others use a liquid stabilization buffer tube, or an FTA-treated card that lyses cells and binds DNA on contact. These are not interchangeable at the bench — a swab collected for a dry-storage protocol and dropped into a liquid-buffer tube (or the reverse) can compromise the extraction. Stock exactly the format the receiving lab’s validated protocol calls for, and keep dry-format and liquid-format kits visually distinct on the shelf so staff can’t reach for the wrong one under time pressure.
Two collection-integrity risks are specific to buccal swabs and worth building into the intake script: recent eating, drinking, smoking, or gum-chewing can dilute or contaminate the sample (most protocols call for a 30- to 60-minute abstention window before collection), and swabbing both cheeks with the same swab, or letting swabs touch each other before sealing, introduces cross-contamination risk between what should be independent samples. Stock individually wrapped swabs, not a shared multi-swab pack, for exactly this reason.
Blood Draw Collection Kits for Genetic Testing
Blood-based collection is the path for most clinical and diagnostic genetic testing — higher-depth sequencing, complex structural-variant analysis, and many payer-reimbursed panels are validated against blood-derived DNA, not buccal, because blood reliably yields more and higher-molecular-weight DNA. The anticoagulant matters: genetic testing labs standardize on EDTA (lavender-top) tubes for genomic DNA extraction, not heparin — heparin can carry over into extracted DNA and inhibit downstream PCR-based assays, which is a common cause of a rejected or failed sample that traces back to tube choice at the draw station, not the lab. Stock EDTA tubes at the fill volume the assay’s minimum-input requirement specifies; an under-filled tube changes the anticoagulant-to-blood ratio and can itself compromise the sample.
Some genetic testing — cell-free DNA work such as noninvasive prenatal testing (NIPT) and liquid-biopsy oncology panels — requires a specialized cell-free DNA stabilization tube rather than a standard EDTA tube. These tubes contain a fixative that stops white-blood-cell lysis and keeps genomic (maternal or non-target) DNA from swamping the small fraction of cell-free target DNA in the sample, and they buy a meaningfully longer room-temperature transport window than a plain EDTA tube can support. If the lab runs or receives cell-free DNA testing, stock this as a distinct SKU from routine EDTA tubes and never substitute one for the other under stockout pressure.
Needle and device selection follows the same clinical logic covered in the site’s butterfly vs. straight needle selection guide — a genetic testing draw is a standard venipuncture from a device standpoint, and skin prep should follow the same protocol as any diagnostic blood draw; see the skin antisepsis before injection guide for antiseptic selection and technique. A genetics-specific station generally does not need a different needle inventory than a standard phlebotomy station stocks — see the Phlebotomy Lab Supply Checklist for the needle-and-tube-range side of the stocking decision, since this checklist focuses on what’s genetics-specific rather than duplicating that ground.
Choosing Between Buccal and Blood Collection for a Given Test
The test being ordered decides the collection path, not station convenience. As a general pattern: NIPT, most clinical diagnostic and carrier-screening panels, pharmacogenomic panels tied to a specific drug-dosing decision, and anything requiring high-depth or structural-variant sequencing typically specify blood. Ancestry and many consumer wellness genomics products, along with some lower-stakes carrier-screening kits, are commonly validated against buccal or saliva collection because the lower DNA-yield ceiling is acceptable for the assay’s design. Forensic, paternity, and immigration-related genetic testing can specify either collection type, but the deciding factor there is usually legal admissibility rather than assay chemistry — those programs typically require a witnessed collection performed by a neutral, non-interested collector, which is a chain-of-custody requirement layered on top of the assay’s own sample requirements.
Whichever path is used, the station needs a clear, test-specific reference — a printed or system-driven lookup from test code to required collection type, tube/kit SKU, and minimum volume — rather than relying on staff memory. A wrong-collection-type error is one of the more common preventable rejection reasons in genetic testing, and it’s a stocking and workflow problem as much as a training one: if the correct kit isn’t visibly, unambiguously in reach, staff default to whatever’s easiest to grab.
Sample-Integrity Chain-of-Custody Basics
Genetic results carry weight a routine lab value doesn’t — they can affect insurance underwriting decisions (which is part of why the federal Genetic Information Nondiscrimination Act, GINA, restricts how health insurers and employers can use genetic test results), paternity and immigration determinations, and criminal or civil legal proceedings. A collection station serving any of those use cases needs to be able to prove, not just assert, that the sample that reached the bench is the sample that was drawn from the named patient. The core elements are the same ones covered in more depth in the site’s forensic chain-of-custody guide, applied to the collection station specifically:
- Positive identity verification at the point of collection — photo ID checked against the requisition, not just a verbal name/date-of-birth confirmation, for any test where legal or insurance stakes attach.
- A witnessed collection, when the test requires it — a second staff member (or, for legally consequential testing, a neutral third party) observes and co-signs that the correct person provided the correct sample.
- Tamper-evident sealing — a numbered tamper-evident bag or seal applied immediately after collection, with the seal number recorded on the custody log, so any break between collection and receipt is visible rather than silent.
- A continuous custody log — every handoff (collector to courier, courier to lab intake, intake to bench) signed, dated, and time-stamped, with no gap in the chain.
- Unique specimen ID matched to the requisition at every step — the same identifier on the tube/swab, the custody log, and the requisition, checked at each handoff rather than assumed to still match.
Not every genetic test needs the full legal-chain-of-custody protocol — a routine clinical carrier-screening panel generally doesn’t need a witnessed collection the way a court-ordered paternity test does. But every genetic test benefits from the identity-verification and specimen-ID-matching steps above, because a mismatched or misidentified genetic sample is a much harder error to catch downstream than a mislabeled routine chemistry panel is.
Labeling, Barcoding, and Requisition Matching
Stock pre-printed or point-of-collection 2D barcode labels rated for the storage conditions the sample will actually see — a label that survives room-temperature transport but delaminates or smears after a freeze-thaw cycle is a real failure mode for any collection path that goes into frozen storage. Labels should print or scan directly from the requisition system so the specimen ID on the tube or swab is generated once and reused everywhere, rather than hand-transcribed at any step. Positive patient ID (name and date of birth, checked against the requisition, not assumed from memory) belongs in the intake script immediately before the label is applied, not after — a correctly labeled sample from the wrong patient is a chain-of-custody failure the label itself can’t catch.
Cold Chain and Transport Stabilization Supplies
Transport temperature requirements vary by collection format and are set by the receiving lab’s validated protocol, not by convenience: many buffer-stabilized buccal kits and cell-free DNA blood tubes are validated for room-temperature transport within a defined window; standard EDTA-tube genomic DNA draws are commonly refrigerated (2–8°C) for anything beyond a same-day courier run; and RNA-based assays typically require frozen (−20°C or colder) transport because RNA degrades faster than DNA outside a stabilized format. Stock insulated shippers sized to the actual kit volume, the correct refrigerant format for the required temperature band (gel packs for refrigerated, dry ice for frozen — not interchangeable, and dry ice shipments carry their own carrier documentation requirements), and single-use temperature-indicator strips or loggers for any shipment where a temperature excursion would void the sample. For multi-site programs standardizing collection kits across locations, see the site’s specimen collection kit standardization guide for the broader kit-consistency problem this same logic extends to.
Consent Documentation and CLIA Context
Many states require a genetic-testing-specific consent form distinct from a general blood-draw consent, and even where it isn’t a state mandate, it’s standard practice for any test whose result could affect insurance, employment, or family-planning decisions — stock a supply of the specific consent form the receiving lab or ordering provider requires, not a generic procedural-consent form repurposed for the occasion. Most genetic testing that returns a patient-specific clinical result runs under CLIA high-complexity certification; see the site’s CLIA high complexity testing requirements guide for what that certification requires of personnel, QC, and validation on the testing side of the lab. A collection station’s job is narrower — get the right sample, from the right patient, into the right kit, with the chain of custody the test requires — but it exists inside that same regulatory frame, and the paperwork the station generates at intake is part of what a CLIA inspection reviews.
Restocking Cadence and Order Quantities
Genetic collection kits differ from routine phlebotomy supplies in one operationally important way: stabilization buffers, FTA cards, and cell-free DNA tubes carry lot-specific expiration dates, and an expired stabilizer can silently degrade a sample without any visible sign at collection time. Track kits by lot number, not just by SKU, rotate stock strictly FIFO (first-expiring, first-used), and set a par-level check on a shorter cycle than generic consumables warrant — weekly rather than monthly for any kit type the station draws down daily, since a lot approaching expiration needs to be identified and used (or discarded) before it lapses, not discovered lapsed mid-collection. Recording the lot number used for each collection also closes the loop with chain-of-custody documentation: if a testing lab later flags a quality issue traced to a specific reagent lot, the collection station needs to be able to identify which patients’ samples used that lot.
Frequently Asked Questions
What’s the real difference between a buccal swab kit and a blood draw kit for genetic testing?
Beyond the obvious collection method, the difference that matters operationally is DNA yield and quality: blood reliably produces more, higher-molecular-weight DNA, which is why most high-depth sequencing, structural-variant, and clinical diagnostic panels are validated against blood. Buccal collection is lower-invasiveness and doesn’t require a phlebotomist, but yields less DNA and is more sensitive to collection-technique errors (recent eating/drinking, cross-contamination between swabs), which is why it’s typically reserved for assays designed around that lower yield ceiling.
Does chain of custody matter for routine clinical genetic testing, not just forensic or legal testing?
The full legal-grade chain of custody (witnessed collection, tamper-evident seal, chain-of-custody form) is specific to testing with legal, immigration, or paternity stakes. But the underlying discipline — positive patient ID, a specimen ID that matches the requisition at every handoff, and a documented custody trail — benefits every genetic test, because a misidentified genetic sample is harder to catch downstream and carries more consequence than a routine lab error.
Can the same EDTA tube used for a CBC be drawn for genetic testing?
Often yes at the anticoagulant level — EDTA is EDTA — but check the receiving lab’s minimum fill volume before assuming a standard CBC-draw tube meets the genetic assay’s input requirement, and never substitute a heparin tube, which can inhibit the PCR-based steps most genetic assays rely on. For cell-free DNA testing specifically (NIPT, liquid biopsy), a standard EDTA tube is not an acceptable substitute for the specialized stabilization tube those assays require.
How is this checklist different from the phlebotomy lab supply checklist?
The Phlebotomy Lab Supply Checklist covers the general high-volume draw-station stocking problem — needle and tube-type range, order-of-draw organization, patient comfort, sharps safety. This checklist assumes that ground is already covered and focuses on what’s specific to a genetic testing lab’s collection station: the buccal-versus-blood collection-path decision, stabilization-chemistry stocking, and the chain-of-custody and cold-chain requirements genetic testing adds on top of a standard draw.
